Thrombotic Thrombocytopenic Purpura Case Study

In this Phase III study, Pharm-Olam partnered with a progressive company to help find a better solution for those suffering with this deadly, rare disease.

Learn More >

Allergic Rhinitis

Allergic rhinitis affects between 10% and 25% of the worldwide population, and is observed most in ecologically unfavorable regions. See our study for more.

Learn More >

Glioblastoma / Anaplastic Astrocytoma Case Study

Glioblastoma / Anaplastic Astrocytoma is a brain tumor with very few available therapies. Learn more about our search for effective treatment options.

Learn More >

Recruitment of Patients in a Phase III Systemic Lupus Erythematosus Study

SLE is a notoriously difficult-to-diagnose autoimmune disorder with no known cure. Our study aimed to find a treatment for severe cases of the disorder.

Learn More >

Rescue and Transfer of a Bioequivalence Breast Cancer Study

Pharm-Olam was called on to rescue a Breast Cancer bioequivalence study. Learn how this transition process successfully supported the study sponsor.

Learn More >

Accuracy and Compliance in a Phase I/II Trial Involving Preterm Neonates

Pharm-Olam provided clinical research services on a pediatric Respiratory Distress Syndrome study. Discover the unique challenges and solutions involved.

Learn More >

Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Pharm-Olam provided a complete enrollment solution for this ABSSSI study. Learn how Pharm-Olam’s efficiency allowed for a quick turnaround in this study.

Learn More >

Systemic Lupus Erythematosus with Lupus Nephritis (Orphan)

Learn how Pharm-Olam overcame difficult enrollment challenges in a massive Systemic Lupus Erythematosus trial and earned high praise from the sponsor.

Learn More >

Automated Sample Retention Solution for BA/BE Studies

BA/BE studies require samples of the investigational product to be retained. Learn about Pharm-Olam’s automated solution that saves time and resources.

Learn More >

Rheumatoid Arthritis

Pharm-Olam rescued a Rheumatoid Arthritis study suffering low enrollment. Learn how Pharm-Olam delivered 75% of the requirement not provided by the other CRO.

Learn More >

Birch and Grass Pollen Allergy Studies

Learn how Pharm-Olam handled challenges such as unpredictable seasons and high patient withdrawal rates in these Birch and Grass Pollen Allergy studies.

Learn More >

Rhinitis, Seasonal

Pharm-Olam rescued this Rhinitis study by recruiting 263 children across 10 centers in Poland in two seasons, gaining praise from the Study Sponsor Manager.

Learn More >

Pediatric Asthma

Pharm-Olam rescued this study begun by another CRO struggling to meet recruitment deadlines. Learn how the successful rescue led to an NDA drug approval.

Learn More >

Glaucoma and Ocular Hypertension

Learn how Pharm-Olam provided monitoring for all 456 patients in this Glaucoma and Ocular Hypertension study, along with other crucial study support.

Learn More >

Prostate Cancer

Learn how Pharm-Olam assisted with strategy and implementation in this prostate cancer study and how it led to more research opportunities with the sponsor.

Learn More >

Breast Cancer

Pharm-Olam aided in the recruitment of 723 patients for this breast cancer study. Learn more about the challenges Pharm-Olam expertly tackled for the sponsor.

Learn More >

Head and Neck Cancer

Learn how Pharm-Olam took over and provided a smooth transition for existing sites and achieve enrollment objectives in this head and neck cancer study.

Learn More >

Post-Operative Pain

Learn how Pharm-Olam provided aggressive enrollment services in this hemorrhoidectomy study and ultimately earned the entire Phase III study from the sponsor.

Learn More >

Post Herpetic Neuralgia

Pharm-Olam’s experience level and proactive approach were critical in the speedy recruitment of patients for this Phase II Post Herpetic Neuralgia study.

Learn More >

Community Acquired Pneumonia

Pharm-Olam provided global project management in this competitive recruitment study, carrying out the sponsor’s needs smoothly and efficiently.

Learn More >

Anemia in Chronic Kidney Disease Patients

Discover how Pharm-Olam handled two challenging studies in anemia with chronic kidney disease patients involving over 25 USA sites and 100 patients.

Learn More >

Acute Myeloid Leukemia

We recommended recruitment sites in Georgia in order to meet deadlines for this study. The sponsor later selected Pharm-Olam to run a second study in the same region.

Learn More >

Pain Treatment After Open Abdominal Hysterectomy

Learn about Pharm-Olam’s role in this abdominal pain treatment study and how we met the enrollment goal 1 week early despite unexpected challenges.

Learn More >

Ulcerative Colitis

Find out how Pharm-Olam rescued a study taking place in France and Belgium by recommending Poland as an enrollment site, meeting requirements far in advance.

Learn More >

Thromboembolism

Learn how Pharm-Olam beat enrollment goals and stayed ahead of schedule in this Phase III study for prevention of blood clots after hip replacement surgery.

Learn More >

Acromegaly (Orphan, Phase III)

Pharm-Olam overcame a long list of challenges in this acromegaly study. Learn how we met enrollment goals and earned an extension study from the sponsor.

Learn More >

Acute Bacterial and Skin Structure Infections (Phase IV and Oral)

Pharm-Olam completed enrollment using only 41 out of the 49 planned sites in this study. Find out what the sponsor had to say about the efficiency of our services.

Learn More >

Pulmonary Arterial Hypertension in Eastern Europe

Pharm-Olam played an integral part in the enrollment of the additional patients in this Phase III study. Discover how we met and surpassed those goals.

Learn More >

Glabellar Lines (Phase II)

Learn how Pharm-Olam approached short recruitment timelines in this Phase II dermatology study and managed to meet deadlines 5 weeks ahead of schedule.

Learn More >

Acromegaly (Orphan, Phase I/II)

Pharm-Olam was contracted to perform and manage all aspects of this Phase I/II Acromegaly study. The sponsor later awarded us their Phase III study.

Learn More >

Crohn's Disease

Learn how Pharm-Olam resolved challenges and met tough deadlines in this Phase III Crohn’s disease study, which ultimately led to a successful FDA application.

Learn More >

Ventilator-Associated Pneumonia Case Study

VAP demands that meticulous care efforts be taken. Pharm-Olam proudly partnered with a progressive drug development company in their search for a solution.

Learn More >